• MHY1485 Workflows for mTOR and Autophagy Studies

  2026-09-24

  Use MHY1485 to probe mTOR activation, autophagosome–lysosome fusion, and ovarian follicle development in controlled research workflows. This guide pairs practical dose-and-time pilot designs with interpretation safeguards, including how to distinguish LC3-II accumulation from increased autophagic flux.

• Bradford Protein Assay Kit: Setup and QC

  2026-09-23

  The Bradford Protein Assay Kit (SKU K4103) provides a rapid colorimetric approach for measuring protein concentration in compatible solution samples. It is suitable for enzyme assays, purification fractions, and molecular biology workflows, but detergent-containing or compositionally atypical samples require compatibility testing and careful interpretation.

• Meropenem: PBP Mechanism and Research Workflows

  2026-09-22

  Meropenem is a β-lactam antibiotic carbapenem that inhibits penicillin-binding proteins and supports research on broad-spectrum antibacterial activity. Its documented handling profile, PBP biology, and preclinical infection-model findings make it useful for controlled in vitro and translational studies, but not as a substitute for clinical susceptibility-guided treatment.

• Mycobacterium tuberculosis WecA: Kinetic Study

  2026-09-22

  A 2026 study establishes a practical workflow for producing and analyzing the difficult-to-express Mycobacterium tuberculosis membrane enzyme WecA. By combining regulated expression in Escherichia coli Lemo21(DE3), affinity purification, mass-spectrometric identification, and UMP-based activity monitoring, the authors provide a foundation for mechanistic studies and inhibitor evaluation.

• MK-2206 Dihydrochloride: Assay Design by Mechanism

  2026-09-21

  MK-2206 dihydrochloride enables mechanism-led interrogation of Akt phosphorylation, apoptosis, and PI3K/Akt/mTOR signaling. This article translates evidence from a glucocorticoid-associated osteonecrosis study into better assay controls, readouts, and cross-domain research decisions.

• Patient-Derived Gastric Cancer Assembloids

  2026-09-21

  This study develops a patient-derived gastric cancer assembloid that combines matched tumor organoids with stromal subpopulations from the same tissue. The model reveals how tumor–stroma composition alters gene expression and drug sensitivity, creating a more informative platform for personalized cancer biology research and resistance studies.

• D-Lin-MC3-DMA for Reliable LNP Cell Assays

  2026-09-20

  This scenario-based guide explains how D-Lin-MC3-DMA (SKU A8791) can be incorporated into siRNA and mRNA lipid nanoparticle workflows while separating delivery effects from cytotoxicity. It covers formulation controls, solvent and storage decisions, assay interpretation, and practical vendor-selection criteria supported by product information and peer-reviewed evidence.

• EZ Cap™ Cas9 mRNA (m1Ψ) Workflow Guide

  2026-09-19

  Build more controlled CRISPR-Cas9 experiments with a transient, Cap1-capped Cas9 mRNA workflow designed for efficient translation and reduced innate immune signaling. This guide connects practical handling and dose optimization with the reference study’s nuclear-export strategy for improving editing precision.

• PDHA1 Acetylation, Cuproptosis, and Enzalutamide Resistance

  2026-09-19

  This study identifies PDHA1 acetylation signaling as a metabolic–epigenetic axis that suppresses cuproptosis and weakens enzalutamide activity in castration-resistant prostate cancer. Its findings connect acetyl-CoA production, H3K27ac, SLC7A11-driven glutathione synthesis, and copper handling, suggesting that PDHA1 targeting may help restore anti-androgen sensitivity in resistant disease.

• Mitoxantrone: Mechanism, Resistance & Research Use

  2026-09-18

  Mitoxantrone is a topoisomerase II inhibitor and anticancer research compound that damages DNA through intercalation and stabilization of the DNA–topoisomerase II complex. Mitozantrone is a spelling variant used in some searches; this article uses the standard name, Mitoxantrone, and explains ABCG2-mediated resistance, product handling, and assay integration.

• IWP-2 Wnt Production Inhibitor Workflow

  2026-09-17

  Build reproducible Wnt pathway experiments with IWP-2 by pairing Porcupine inhibition with orthogonal transcriptional, phenotypic, and apoptosis readouts. The workflow separates literature-backed product performance from practical optimization, helping researchers move from gastric cancer models to carefully bounded cross-domain assay design.

• GDC-0068 (RG7440) Pan-AKT Inhibitor

  2026-09-17

  GDC-0068, also known as RG7440, is an ATP-competitive pan-AKT inhibitor that targets Akt1, Akt2, and Akt3. Product information supports its use as a research tool for studying PI3K/Akt/mTOR signaling, cell-cycle control, and preclinical tumor models, especially those with PTEN loss or PI3K pathway activation.

• HO-1, ROS, and HBV Replication: ICAA Study

  2026-09-16

  A recent Antiviral Research study shows that isochlorogenic acid A suppresses HBV at multiple stages, including transcription, genome production, cccDNA maintenance, capsid formation, and envelopment. Its mechanistic contribution is the connection of these antiviral effects with HO-1 upregulation and altered intracellular ROS, while also identifying viral protein thiol chemistry as a possible link to defective morphogenesis.

• Nitrocefin Workflows for β-Lactamase Assays

  2026-09-16

  Nitrocefin converts β-lactamase hydrolysis into a visible and spectrophotometric signal, making it useful for resistance profiling, mechanistic enzyme studies, and inhibitor screening. This workflow-focused guide connects assay setup and troubleshooting with the 2024 structure-guided peptide discovery study targeting TEM-1 β-lactamase.

• Tin Mesoporphyrin IX: HO Assay Workflows

  2026-09-15

  A practical guide to using Tin Mesoporphyrin IX (chloride) as a direct pharmacological probe of heme oxygenase activity. The workflow connects enzyme inhibition with metabolic, ROS, and HBV-related assays while emphasizing controls, dose selection, and troubleshooting.

8711 records 1/581 page Next 12345 下5页 Last page